Cellular and T cell engager Immunotherapy
Barriers to the Implementation of Bispecific Antibodies for patient with Relapsed and Refractory Myeloma in the UK: Results of a National Survey
May Low, MPharm, MSc, IP
Senior Haematology Pharmacist
University College London Hospitals
London, United Kingdom